Dr. Ciara Conlan:

Malaysia has taken a compulsory licence for sofosbuvir and it is producing and selling the medicine. More recently, this has been discussed in parliaments in Europe, most recently in the UK, where there is still no access under the NHS to Orkambi. This was raised in the UK Parliament as a means of securing access to the drug because the price was too high to afford in any other way.